Median Compressive Neuropathy Proximal to the Carpal Tunnel

Galvez, Michael G.; Yao, Jeffrey

doi:10.1007/978-3-319-57010-5_28

Cited by 1 publication

(2 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[2,3] These will seriously affect the quality of daily life of patients. [4] CTS, as one of the common orthopedic diseases, epidemiological studies have found that the adult prevalence is 3% to 6%, the patient group is more common in women, 2 to 4 times more than men, and the peak age of onset is between Liu et al • Medicine (2023) 102: 9 Medicine 45 and 54 years. [5][6][7] With reference to the severity of the patient symptoms and the duration of the disease, different treatment plans can be developed, and most patients can get significant relief with conservative treatment, of which glucocorticoid intrathecal injection is the classical treatment plan, [8] but the 2014 European CTS treatment guidelines recommend that closed treatment should not exceed 3 times and the interval between 2 closed treatments is 2 to 3 months.…”

Section: Introductionmentioning

confidence: 99%

“…[5][6][7] With reference to the severity of the patient symptoms and the duration of the disease, different treatment plans can be developed, and most patients can get significant relief with conservative treatment, of which glucocorticoid intrathecal injection is the classical treatment plan, [8] but the 2014 European CTS treatment guidelines recommend that closed treatment should not exceed 3 times and the interval between 2 closed treatments is 2 to 3 months. [9] Meanwhile, the Chinese traditional treatment method represented by small needle knife has also achieved satisfactory results in the treatment of carpal tunnel syndrome, which can effectively release the transverse carpal ligament to achieve the effect of releasing carpal tunnel pressure and median nerve compression. [10,11] The vast majority of patients with nonrecalcitrant carpal tunnel syndrome can be treated satisfactorily with conservative rather than surgical treatment.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Comparison of acupotomy release combined with glucocorticoid intrathecal injection versus isolated glucocorticoid intrathecal injection for carpal tunnel syndrome: A protocol for a meta-analysis of comparative studies

Liu¹,

Yang

Dong

et al. 2023

Medicine

View full text Add to dashboard Cite

Background: Carpal tunnel syndrome (CTS) is more common in people who need to engage in repetitive wrist work. Once it has occurred, localized pain and numbness of the fingers will develop, in severe cases, muscle atrophy will even arise, and after rest and physical therapy, many patients will still be unable to relieve or recur. In this case, the patient can receive intrathecal glucocorticoid injections, but the hormone injections alone can only provide short-term relief, and because the mechanical factors of median nerve compression are not fundamentally removed. Therefore, combined acupotomy release can help to release the compression of the transverse carpal ligament on the nerve and increase the volume within the carpal tunnel to achieve more satisfactory long-term results. Hence, a meta-analysis is necessary to provide evidence whether there is a significant difference in the treatment of CTS with acupotomy release combined with glucocorticoid intrathecal injection (ARGI) compared with isolated glucocorticoid intrathecal injection (GI).Methods: We will search, with no time restriction, without any restriction of language and status, the time from the establishment of the database to October 2022, on the following databases: PubMed, Cochrane central register of controlled trials, Web of Science, Chinese national knowledge infrastructure, Wanfang data, Chinese scientific journals database, Chinese databases SinoMed, and electronic databases. The electronic database search will be supplemented by a manual search of the reference lists of included articles. We will apply the risk-of-bias tool of the Cochrane collaboration for randomized controlled trials to assess the methodological quality. Risk-of-Bias Assessment Tool for nonrandomized studies was used to evaluate the quality of comparative studies. Statistical analysis will be conducted using RevMan 5.4 software.Results: This systematic review will evaluate the difference in efficacy of ARGI versus isolated GI in the treatment of CTS. Conclusion:The conclusion of this study will provide evidence for judging whether ARGI is superior to GI for treatment of CTS.Abbreviations: ARGI = acupotomy release combined with glucocorticoid intrathecal injection, CTS = carpal tunnel syndrome, GI = glucocorticoid intrathecal injection, PRISMA-P = preferred reporting items for systematic review and meta-analysis protocols.

show abstract